Shorepoint Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.78M | Buy |
61,924
+3,498
| +6% | +$213K | 0.85% | 51 |
|
|
2024
Q4 | $3.3M | Buy |
58,426
+1,248
| +2% | +$70.6K | 0.76% | 53 |
|
|
2024
Q3 | $2.96M | Sell |
57,178
-28,497
| -33% | -$1.47M | 0.67% | 63 |
|
|
2024
Q2 | $3.56M | Sell |
85,675
-8,753
| -9% | -$364K | 0.84% | 48 |
|
|
2024
Q1 | $5.12M | Buy |
94,428
+2,788
| +3% | +$151K | 1.25% | 30 |
|
|
2023
Q4 | $4.7M | Buy |
91,640
+5,849
| +7% | +$300K | 1.26% | 32 |
|
|
2023
Q3 | $4.98M | Buy |
85,791
+4,075
| +5% | +$237K | 1.46% | 22 |
|
|
2023
Q2 | $5.23M | Buy |
81,716
+829
| +1% | +$53K | 1.47% | 24 |
|
|
2023
Q1 | $5.61M | Sell |
80,887
-3,705
| -4% | -$257K | 1.6% | 20 |
|
|
2022
Q4 | $6.09M | Buy |
84,592
+1,076
| +1% | +$77.4K | 1.69% | 17 |
|
|
2022
Q3 | $5.94M | Buy |
83,516
+1,453
| +2% | +$103K | 2.83% | 6 |
|
|
2022
Q2 | $6.32M | Sell |
82,063
-4,273
| -5% | -$329K | 2.67% | 6 |
|
|
2022
Q1 | $6.31M | Sell |
86,336
-931
| -1% | -$68K | 2.63% | 8 |
|
|
2021
Q4 | $5.44M | Buy |
87,267
+3,208
| +4% | +$200K | 2.21% | 13 |
|
|
2021
Q3 | $4.97M | Buy |
+84,059
| New | +$4.97M | 2.24% | 13 |
|
|
2021
Q1 | $4.49M | Buy |
71,051
+6,099
| +9% | +$385K | 2.4% | 10 |
|
|
2020
Q4 | $4.03M | Buy |
64,952
+2,504
| +4% | +$155K | 2.23% | 12 |
|
|
2020
Q3 | $3.77M | Buy |
62,448
+7,339
| +13% | +$442K | 2.34% | 12 |
|
|
2020
Q2 | $3.24M | Buy |
55,109
+21,499
| +64% | +$1.26M | 2.11% | 12 |
|
|
2020
Q1 | $1.87M | Buy |
+33,610
| New | +$1.87M | 1.5% | 29 |
|